 |
|
Current status and outcome of liver transplantation in South Korea
Ho Joong Choi
Clin Mol Hepatol. 2022;28(1):117-119. Published online 2021 Dec 7 DOI: https://doi.org/10.3350/cmh.2021.0381
|
|
Citations to this article as recorded by
 How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Byeong Geun Song, Dong Hyun Sinn
Clinical and Molecular Hepatology.2023; 29(2): 411. CrossRef Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation
Jeong-Ju Yoo, Jong-In Chang, Ji Eun Moon, Dong Hyun Sinn, Sang Gyune Kim, Young Seok Kim
Liver Transplantation.2023; 29(10): 1029. CrossRef Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
Clinical and Molecular Hepatology.2023; 29(3): 593. CrossRef The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
Kunhee Kim, Deok-Gie Kim, Jae Geun Lee, Dong Jin Joo, Hye Won Lee
Yonsei Medical Journal.2023; 64(11): 647. CrossRef The first successful report of liver transplantation from category III donation after circulatory death in South Korea: a case report
Incheon Kang, Jae-myeong Lee, Jae Geun Lee
Korean Journal of Transplantation.2022; 36(4): 294. CrossRef
|